Dr Seyed Aidin Sajedi

1. Mohammadianinejad SE, Abbasi V, Sajedi SA, Majdinasab N, Abdollahi F, Hajmanouchehri R, et al. Zonisamide versus topiramate in migraine prophylaxis: a double-blind randomized clinical trial. Clinical neuropharmacology. 2011;34(4):174-7

2. Shahripour RB, Mohammadianinejad SE, Sajedi SA, Tarahhomi S. Report of a Known Case of Rheumatoid Arthritis and Cerebral Vasculitis with a Proper Response to Corticosteroid and Cyclophosphamide Pulse Therapy. Journal of Isfahan Medical School. 2011;29(129); 188-195

3. Shahripour RB, Shamsaei G, Pakdaman H, Majdinasab N, Nejad EM, Sajedi SA, et al. The effect of NeuroAiD™(MLC601) on cerebral blood flow velocity in subjects' post brain infarct in the middle cerebral artery territory. European journal of internal medicine. 2011;22(5):509-13

4. Sajedi SA, Abdollahi F. Geomagnetic disturbances may be environmental risk factor for multiple sclerosis: an ecological study of 111 locations in 24 countries. BMC neurology. 2012;12(1):1

5. Azarpazhooh MR, Shahripour RB, Kapral MK, Mokhber N, Shoeibi A, Farzadfard MT, Rafati MR, Thrift AG, Morovatdar N, Sajedi SA, Azarpazhooh A. Incidence of first ever stroke during Hajj ceremony. BMC neurology. 2013;13(1):1

6. Abdollahi F, Sajedi SA. Correlation of multiple sclerosis (MS) incidence trends with solar and geomagnetic indices: Time to revise the method of reporting MS epidemiological data. Iranian journal of neurology. 2014;13(2):64-69

7. Mohammadianinejad SE, Majdinasab N, Sajedi SA, Abdollahi F, Moqaddam MM, Sadr F. The effect of lithium in post-stroke motor recovery: a double-blind, placebo-controlled, randomized clinical trial. Clinical neuropharmacology. 2014;37(3):73-8

8. Shahripour RB, Mortazavi MM, Barlinn K, Keikhaei B, Mousakhani H, Azarpazhooh MR, Oghbaee M, Sajedi SA, Kepplinger J, Tubbs RS, Albright KC, Alexandrov AV. Can STOP Trial Velocity Criteria Be Applied to Iranian Children with Sickle Cell Disease? Journal of stroke. 2014;16(2):97-101

9. Sajedi SA, Abdollahi F. Geomagnetic disturbance: A new field in multiple sclerosis research. Clinical Neurology and Neurosurgery. 2016: 151; 142

10. Sajedi SA, Abdollahi F. Multiple Sclerosis and Geomagnetic Disturbances: Investigating a Potentially Important Environmental Risk Factor. In: Ibaraki M, Mori H, editors. Progress in Medical Geology.​ Cambridge Scholars Publishing; Newcastle. 2017 

11. Sajedi SA, Abdollahi F. Which Environmental Factor Is Correlated with Long-Term Multiple Sclerosis Incidence Trends: Ultraviolet B Radiation or Geomagnetic Disturbances? Multiple Sclerosis International. 2017: 1-11

12. Iaffaldano P, Simone M, G Lucisano G, (...), Sajedi SA, (...), McCombefrom P, Grand'Maison F. Prognostic indicators in pediatric clinically isolated syndrome. Annals of Neurology. 2017; 81 (5): 729-739

13. Abdollahi F, Sajedi SA, Majdinasab N, Saghatoleslami M, Rad HS, Ghorbani A, Kiarashi N. Is there an association between brain iron accumulations with blood iron metabolism markers in multiple sclerosis patients?. Multiple Sclerosis International. 2017; 23 (1): 12-12

14. Sajedi SA. Time to consider alternative environmental risk factor rather than ultra violet-B for multiple sclerosis. Multiple Sclerosis and Related Disorders. 2018: 24; 47

15. Signori A, Izquierdo G, Lugaresi A, (...), Sajedi SA, (...), Sormani, MP, Trojano M. Long-term disability trajectories in primary progressive MS patients: A latent class growth analysis. Multiple Sclerosis Journal. 2018: 24 (5): 642-652

16. Hughes J, Jokubaitis V, Lugaresi A, (...), Sajedi SA, (...), Quddus, S, Hinson E. Association of Inflammation and Disability Accrual in Patients with Progressive-Onset Multiple Sclerosis. JAMA Neurology. 2018; 75 (11):1407-1415

17. Mohammadianinejad SE, Majidinasab N, Nejati A, Hatamian H, Mehramiri A, Sajedi SA, Hesam S. Tapering Oral Steroid Treatment After IV Methylprednisolone Pulse Therapy in Demyelinating Optic Neuritis. Caspian Journal of Neurological Sciences. 2018; 4 (1): 1-5

18. Sajedi SA. Reader response: Incidence of MS has increased markedly over 6 decades in Denmark particularly with late onset and in women. Neurology.2019; 92 (8): 397